ImmunoForge Competitors and Similar CompaniesClear all
ImmunoForge's competitors and similar companies include Syndax Pharmaceuticals and OSE Immunotherapeutics.
 Syndax Pharmaceuticals Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy. |  OSE Immunotherapeutics OSE Immunotherapeutics is a biotechnology company that focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. | ||
Founding Date | Founding Date 2017 | Founding Date 2005 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations KR HQ King Of Prussia, US | Locations Waltham, US HQ New York, US Waltham, US | Locations Nantes, FR HQ Paris, FR |
Employees | Employees 4 | Employees 358% decrease | Employees 52 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) 239 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $172.4m (FY, 2025) | Revenue (est.) €69.9m (FY, 2024) |
Net income | Net income N/A | Net income ($285.4m) (FY, 2025) | Net income €37.4m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Syndax Pharmaceuticals
HQ
Waltham, US
Employees
35↓ 8% decrease
Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
View companyOSE Immunotherapeutics
HQ
Nantes, FR
Employees
52
OSE Immunotherapeutics is a biotechnology company that focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases.
View company